miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.

作者: Limin Zhai , Chuanxiang Ma , Wentong Li , Shuo Yang , Zhijun Liu

DOI: 10.1002/MC.22445

关键词:

摘要: Epithelial-mesenchymal transition (EMT) plays a pivotal role in the development of cancer invasion and metastasis. Many studies have significantly enhanced knowledge on EMT through characterization microRNAs (miRNAs) influencing signaling pathways downstream events that define molecular level. In this study, we found miR-143 suppressed EMT. Up-regulating E-cadherin-mediated cell-cell adhesion ability, reduced mesenchymal markers, decreased cell proliferation, migration, vitro. vivo, xenograft mouse model also unveiled suppressive effects tumor growth. Additionally, demonstrated up-regulating extracellular signal regulated kinase 5 (ERK5) was associated with poor prognosis breast patients. Moreover, observed an inverse correlation between ERK5 tissues. directly targeted seed sequences 3'-untranslated regions ERK5. Furthermore, revealed molecules glycogen synthase 3 beta (GSK-3β)/Snail were involved modulated by summary, our findings down-regulated its target ERK5, leading to suppression induced GSK-3β/Snail cancer. © 2015 Wiley Periodicals, Inc.

参考文章(28)
Yi Chen, Dongke Yu, Caixia Zhang, Boyang Shang, Hongwei He, Jinjing Chen, Hao Zhang, Wuli Zhao, Zhen Wang, Xiaoyu Xu, Yongsu Zhen, Rong‐guang Shao, Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β‐catenin pathway Molecular Carcinogenesis. ,vol. 54, pp. 1- 8 ,(2015) , 10.1002/MC.22069
James A. McCubrey, Linda S. Steelman, Fred E. Bertrand, Nicole M. Davis, Melissa Sokolosky, Steve L. Abrams, Giuseppe Montalto, Antonino B. D’Assoro, Massimo Libra, Ferdinando Nicoletti, Roberta Maestro, Jorg Basecke, Dariusz Rakus, Agnieszka Gizak, Zoya Demidenko, Lucio Cocco, Alberto M. Martelli, Melchiorre Cervello, GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. ,vol. 5, pp. 2881- 2911 ,(2014) , 10.18632/ONCOTARGET.2037
Jason Harquail, Sami Benzina, Gilles A. Robichaud, MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomarkers. ,vol. 11, pp. 269- 280 ,(2012) , 10.3233/CBM-120291
James W. Antoon, Elizabeth C. Martin, Rongye Lai, Virgilo A. Salvo, Yan Tang, Ashley M. Nitzchke, Steven Elliott, Seung Yoon Nam, Wei Xiong, Lyndsay V. Rhodes, Bridgette Collins-Burow, Odile David, Guandi Wang, Bin Shan, Barbara S. Beckman, Kenneth P. Nephew, Matthew E. Burow, MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis PLoS ONE. ,vol. 8, pp. e69291- ,(2013) , 10.1371/JOURNAL.PONE.0069291
Young-Mi Ham, Sarah Jane Mahoney, Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72. Experimental Cell Research. ,vol. 319, pp. 1451- 1462 ,(2013) , 10.1016/J.YEXCR.2013.02.016
David J Drasin, Tyler P Robin, Heide L Ford, Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity Breast Cancer Research. ,vol. 13, pp. 226- 226 ,(2011) , 10.1186/BCR3037
Cyrielle Clapé, Vanessa Fritz, Corinne Henriquet, Florence Apparailly, Pedro Luis Fernandez, François Iborra, Christophe Avancès, Martin Villalba, Stéphane Culine, Lluis Fajas, miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice PLoS ONE. ,vol. 4, pp. e7542- ,(2009) , 10.1371/JOURNAL.PONE.0007542
Christopher E.P. Goldring, Jürgen Müller, Michael J. Cross, Gopika N. Nithianandarajah-Jones, Bettina Wilm, ERK5: structure, regulation and function. Cellular Signalling. ,vol. 24, pp. 2187- 2196 ,(2012) , 10.1016/J.CELLSIG.2012.07.007
Donita C. Brady, Matthew S. Crowe, Michelle L. Turski, G. Aaron Hobbs, Xiaojie Yao, Apirat Chaikuad, Stefan Knapp, Kunhong Xiao, Sharon L. Campbell, Dennis J. Thiele, Christopher M. Counter, Copper is required for oncogenic BRAF signalling and tumorigenesis Nature. ,vol. 509, pp. 492- 496 ,(2014) , 10.1038/NATURE13180
Stefano Volinia, Gerard Nuovo, Alessandra Drusco, Stefan Costinean, Ramzey Abujarour, Caroline Desponts, Michela Garofalo, Raffaele Baffa, Rami Aeqilan, Kati Maharry, Maria Elena Sana Ramiro Garzon, Gianpiero Di Leva, Pierluigi Gasparini, Paola Dama, Jlenia Marchesini, Marco Galasso, Marco Manfrini, Carlotta Zerbinati, Fabio Corrà, Timothy Wise, Sylwia E. Wojcik, Maurizio Previati, Flavia Pichiorri, Nicola Zanesi, Hansjuerg Alder, Jeff Palatini, Kay F. Huebner, Charles L. Shapiro, Massimo Negrini, Andrea Vecchione, Anne L. Rosenberg, Carlo M. Croce, Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer JNCI: Journal of the National Cancer Institute. ,vol. 106, pp. 1- 8 ,(2014) , 10.1093/JNCI/DJU324